(Q42754409)

6 November 2017

title

Effect of metyrapone on the fluoxetine-induced change in extracellular dopamine, serotonin and their metabolites in the rat frontal cortex (English)

1 reference

6 November 2017

1

Zofia Rogóż

1 reference

6 November 2017

Krystyna Gołembiowska

series ordinal

2

object named as

Krystyna Gołembiowska

1 reference

6 November 2017

publication date

1 November 2010

1 reference

6 November 2017

published in

Pharmacological Reports

1 reference

6 November 2017

volume

62

1 reference

6 November 2017

issue

6

1 reference

6 November 2017

page(s)

1015-1022

1 reference

Corticosterone influences forced swim-induced immobility

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Buspirone augmentation of antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Metyrapone displays antidepressant-like properties in preclinical paradigms.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

The corticosteroid receptor hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

The effect of tianeptine and sertraline in three animal models of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Cytochrome P450 2D Catalyze Steroid 21-Hydroxylation in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Are CRF receptor antagonists potential antidepressants?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Treatment of major depression with metyrapone and hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Induction of rat hepatic glucocorticoid-inducible cytochrome P450 3A by metyrapone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970363-7

7 January 2021

10.1016/S1734-1140(10)70363-7

Identifiers

DOI

1 reference

6 November 2017

1 reference